Wuhu DeTech Future Co.,Ltd., a start-up company found in 2018, located in the national economic and technological development zone, Wuhu, China. Our company is lead by the elites expertise in optical imaging, materials, semiconductor technology and TFT-array design.We are developing the next generation X-ray plate detector and Liquid crystal antenna.
Wuhan Healthgen Biotechnology Corp.
Wuhan Healthgen Biotechnology Corp. (Stock Code: 668765) is a molecular pharmaceutical company specializing in the development, manufacturing, and marketing of recombinant proteins. Using its proprietary OryzHiExp platform, Healthgen achieves high-yield expression of proteins and peptides in rice grains. Its flagship product, Recombinant Human Serum Albumin (OsrHSA), is a critical reagent used in cell culture, medical devices, biopharmaceutical excipients, and cosmetic additives.
Wolf X-Ray Corporation
Wolf X-Ray Corporation is a long-established U.S. manufacturer and distributor of medical and dental imaging accessories and radiation-protection products. Founded in 1931, the company supplies items such as lead aprons, mobile shields, X-ray markers, film and digital imaging accessories, and safety equipment for hospitals, imaging centers, and dental practices. Wolf X-Ray is recognized for durable, U.S.-made products designed to support radiation safety and imaging workflow.
WIENER LAB.
We develop, manufacture and market integrated solutions that enable IVD diagnostics in more than 50 countries around the world. We offer a broad line of products for clinical laboratories and blood banks that enable accurate and timely diagnoses. We generate key and relevant information for medical decision making, understanding the laboratory as a crucial link in the health chain. | We develop, manufacture and market integrated solutions that enable IVD diagnostics in more than 50 countries around the world. We offer a broad line of products for clinical laboratories and blood banks that enable accurate and timely diagnoses. We generate key and relevant information for medical decision making, understanding the laboratory as a very important player in the health system. | Wiener lab. is an innovation-driven multinational from Argentina, with over six decades of experience in the in vitro diagnostics (IVD) industry. With a presence in more than 50 countries, the company continues to grow across Latin America, South Asia, and Europe. Its mission is to deliver smart, reliable, and accessible diagnostic solutions for healthcare systems worldwide. At the heart of its innovation engine is the Centre for Research and Biotechnology (CIBio), where a diverse team of scientists and engineers leads the development of new technologies. The company promotes open innovation by fostering strategic partnerships with academic institutions, regulatory bodies, and clinical collaborators. Wiener lab. actively seeks global partners for OEM manufacturing, technology transfer, and co-development projects. These collaborations are essential for enhancing technological capabilities and providing quicker, more adaptable solutions to meet evolving healthcare demands. The product portfolio includes clinical chemistry, molecular biology, hematology, hemostasis, immunology, urinalysis, chemiluminescence, and ESR, all developed in certified manufacturing facilities that comply with ISO and FDA requirements.
WIDE-USA Corporation
WIDE-USA | Global Leaders in Diagnostic & Specialty Display Solutions Since 2000, WIDE-USA has been at the forefront of medical-grade monitors, diagnostic imaging displays, and air traffic control visualization systems. What began as a bold vision by six founders has evolved into an internationally recognized brand trusted by hospitals, radiology groups, and mission-critical industries worldwide. Our expertise lies in the design, development, manufacturing, distribution, and service of advanced display technologies that meet the demanding requirements of modern healthcare and professional visualization environments. From radiology PACS workstations to air traffic control centers, WIDE monitors are engineered for accuracy, reliability, and long-term performance. At WIDE, we prioritize customer-driven innovation. Through ongoing investment in research and development, we continually refine our technology to address real-world challenges faced by radiologists, clinicians, and operational teams. Our monitors are designed for precision diagnostic imaging, DICOM calibration, compliance with industry standards, and user-focused reliability—ensuring accuracy where it matters most. With more than two decades of industry leadership, WIDE-USA remains committed to setting new standards in medical display solutions. Our mission is clear: deliver exceptional visualization technology backed by responsive service and strong partnerships, helping healthcare organizations improve outcomes and efficiency. Experience WIDE-USA at RSNA—where innovation, reliability, and customer satisfaction define the future of diagnostic and specialty monitors.
WhiteStar Communications
Provider of high performance, ultra secure network platform to provide remote medical equipment access and control for telemedicine, as well as secure medical records transfers. We empower societies with trusted, secure, private communications. Works with any legacy software with no changes required.
West Pharmaceutical Services
West Pharmaceutical Services, Inc. is a leading provider of innovative, high-quality injectable solutions and services. As a trusted partner to established and emerging drug developers, West helps ensure the safe, effective containment and delivery of life-saving and life-enhancing medicines for patients. With 10,000 team members across 50 sites worldwide, West helps support our customers by delivering approximately 47 billion components and devices each year. 2023 marks West’s 100-year milestone of innovation and the critical role it continues to play in healthcare and the patient experience. Headquartered in Exton, Pennsylvania, West in its fiscal year 2022 generated $2.89 billion in net sales. West is traded on the New York Stock Exchange (NYSE: WST) and is included on the Standard & Poor’s 500 index. For more information, visit www.westpharma.com. | West Pharmaceutical Services, Inc. is a leading provider of innovative, high-quality injectable solutions and services. As a trusted partner to established and emerging drug developers, West helps ensure the safe, effective containment and delivery of life-saving and life-enhancing medicines for patients. With 10,000 team members across 50 sites worldwide, West helps support our customers by delivering approximately 47 billion components and devices each year. In 2023, West commemorated a century of groundbreaking innovation that has shaped the landscape of healthcare and impacted the lives of patients around the world. This milestone served as a testament to West’s commitment to revolutionize drug delivery and enhance the overall patient experience. Headquartered in Exton, Pennsylvania, West in its fiscal year 2022 generated $2.89 billion in net sales. West is traded on the New York Stock Exchange (NYSE: WST) and is included on the Standard & Poor’s 500 index. For more information, visit www.westpharma.com. | West Pharmaceutical Services, Inc. is a leading provider of innovative, high-quality injectable solutions and services. As a trusted partner to established and emerging drug developers, West helps ensure the safe, effective containment and delivery of life-saving and life-enhancing medicines for patients. With over 10,000 team members across 50 sites including 25 manufacturing facilities worldwide, West helps support our customers by delivering over 41 billion components and devices each year. Headquartered in Exton, Pennsylvania, West in its fiscal year 2024 generated $2.89 billion in net sales. West is traded on the New York Stock Exchange (NYSE: WST) and is included on the Standard & Poor’s 500 index. For more information, visit www.westpharma.com.